MRSA
(Adobe Stock, unknown)
(This article first appeared in our sister brand, ContagionLive.com.)
Acute care hospitals are significant settings for Methicillin-resistant Staphylococcus aureus (MRSA) healthcare-associated infections (HAIs), which are opportunistic bacterium that are challenging to try to prevent.
With many acute care hospitals, the Veterans Administration (VA) is an effective health care system and an excellent source to study how to prevent MRSA. The appearance of COVID-19, however, forced many facilities to focus their resources on the pandemic. For example, at the onset of the pandemic, all 123 acute care VA health care facilities were offered the option to suspend any combination of active surveillance (AS), contact precautions for patients colonized (CPC) or infected (CPI) with MRSA to free up laboratory resources for COVID-19 testing and conserve personal protective equipment.
Initially, only 20% of facilities continued all 3 MRSA infection control measures in July 2020, which increased to 57% by June 2022.
In a new study, those facilities that carried out these practices saw a reduction in MRSA.
“In VA, there were fewer MRSA HAIs when facilities practiced active surveillance and contact precautions for colonized or infected patients during the COVID-19 pandemic,” the authors wrote.
The study, “Active Surveillance and Contact Precautions for Preventing MRSA Healthcare-Associated Infections during COVID-19 Pandemic,” was presented at the SHEA conference this week, held in Seattle, Washington, from April 11-14, 2023.
The investigators performed a prospective cohort study from July 2020–June 2022. During their analysis period, there were 917,591 admissions, 5,225,174 patient days, and 568 MRSA HAIs.
Not only did they see a reduction when infection prevention methods were continued, but the investigators also noted the effect was more significant in ICUs than in non-ICU settings.
“The MRSA HAI rate for all infection sites in non-ICUs was 0.07 (95% CI 0.05-0.08) for facilities practicing AS + CPC + CPI compared to 0.12 (95% CI 0.08-0.19, P = 0.01) for those not practicing any of these strategies,” the investigators wrote. and in ICUs was 0.20 (95% CI 0.15-0.26) and 0.65 (95% CI 0.41-0.98, P < 0.001) for the respective policies,” the investigators wrote.
They also said similar differences were seen when the analyses were restricted to MRSA bloodstream HAIs.
Herpes and Dentistry: A Silent But Serious Concern
February 21st 2025Herpes infections pose significant risks in dentistry. JoAnn Gurenlian, RDH, PhD, presented prevention, treatment, occupational hazards, and a potential breakthrough in gene therapy that could revolutionize herpes management at the Midwinter Meeting.
Chicago Dental Society Honors Drs Joseph Hagenbruch and Mark Lingen for Excellence in Dentistry
February 21st 2025The Chicago Dental Society honored Dr. Joseph Hagenbruch and Dr. Mark Lingen for their leadership, research, and dedication to advancing dentistry and improving oral health care access.
From Sterilization Tech to Infection Control Advocate: Sherrie Busby’s Inspiring Dental Journey
February 20th 2025Sherrie Busby, EDDA, CDSO, CDIPC, shares her journey from dental assisting to infection control advocacy, highlighting her passion for education, her role at Heartland Dental, and her exciting transition to a new chapter.
Innovation and Infection Control: Highlights From W&H at Chicago Dental Midwinter Society Meeting
February 19th 2025Doris Schneider, senior marketing manager for North America for W&H North America, shares insights into the 160th Chicago Dental Society Midwinter Meeting, showcasing the Lexa Mini rapid sterilizer and Sanaa Power handpiece, designed for efficient sterilization and effortless dental procedures.